marijuana stocks news

Namaste Signs Cannabis Purchase Agreement With Tilray®

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) is pleased to announce that the Company has signed a purchase agreement (the “Purchase Agreement”) with Tilray Canada Ltd., a subsidiary of Tilray Inc. (TLRY), whereby the Company will purchase bulk medical cannabis products from Tilray, to be sold on Namaste’s e-commerce platform through its wholly-owned subsidiary Cannmart Inc. (“Cannmart”).

With Cannmart’s anticipated sales license imminent, the Company continues to aggressively seek and secure partnerships with the top global ACMPR Licensed Producers as it looks to implement its strategy. The Supply Agreement with Tilray Canada will add significant value to Cannmart’s current product offering, and Namaste is incredibly excited to be able to offer patients Tilray’s selection of high quality, pharmaceutical-grade medical cannabis products.

Tilray is a global leader in the research, cultivation, production and distribution of cannabis and cannabinoids, and currently serve tens of thousands of patients in eleven countries, spanning five continents. The Supply Agreement represents a significant milestone for Namaste and paves the way for future partnerships in global markets where the Company maintains strong market share.

Namaste remains committed to all of its medical cannabis patients by providing the most comprehensive patient experience possible through its online platform. By supplying inventory to Cannmart, Tilray’s high-quality products will be available to Cannmart’s patients. This partnership will not only allow patients on Namaste’s platform to select from Tilray’s variety of high-quality medical cannabis products, but so too will it add significant value for Cannmart’s patients and the Company as a whole.

The Company continues to integrate leading technology platforms including its online patient portal, NamasteMD (“NamasteMD.com”) and its proprietary AI technology, with the goal of providing its patients with the most expansive product offering in the industry. The Company recently launched My Uppy Cannabis Journal, which is an AI-driven patient feedback app (available for Apple and Android devices). In doing so, Namaste believes that it has the capability of offering its patients an exceptional buying experience, that can be personalized to meet each patient’s individual needs.

Management Commentary

Sean DollingerPresident and CEO of Namaste comments: “We’re very proud to have signed a Purchase Agreement with Tilray, who we believe are one of Canada’s leading Licensed Producers. We have already had customers from NamasteMD ordering products through Tilray and the response has been overwhelmingly positive. As such, we are looking forward to offering Tilray’s high-quality products in our platform.

Namaste’s goal of becoming Canada’s leading medical cannabis e-commerce platform has once again been reinforced through the signing of this strategic Supply Agreement with an industry leader like Tilray. Namaste feels incredibly lucky to have the opportunity of working with a true pioneer to the industry. We’re looking forward to offering Tilray’s products to our patients and in providing an exceptional user experience for each and every patient through Cannmart.com.”


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

High Tide Inc. (HITI) To Open Second Canna Cabana Location in Brampton, Ontario

High Tide To Open Second Canna Cabana Location in Brampton, Ontario High…

SNDL Inc. (SNDL) to Announce Third Quarter 2022 Financial Results on November 14, 2022

SNDL to Announce Third Quarter 2022 Financial Results on November 14, 2022…

$CNAB Signs Consulting Agreement

United Cannabis Corporation Signs Consulting Agreement With Extraction Pioneer Marcus “Bubbleman” Richardson…